information for new investors, page-146

re: novogen - the best stock on the asx ToX,
You are referring to post 1 of this thread. You will find this:

" The elaborate version:

Page 9: http://tinyurl.com/dzyj
____________________________

That is the Software library. It is updated within 48 hours (usually 24 hours) and is in big demand by many investors.

Once every 4 weeks or so depending on the scale of the Announcements, it is sent to a number of people using our ISP email addresses. Thus the presentation is much better than in the above mentioned web address.

Who uses it? Everybody who wants to get quickly up to speed but also very experienced Investors. I use it all the time as a lot of it is a journal. So, answers to questions are usually found there.

Having it available means also that often the routine questions are not asked and the NRT site is is not cluttered. People simply refer to this. It has the web addresses from the principal companies at the very beginning.

This library is becoming more important with time. That is because say successive trials with Phenox. on Gyn. cancers, its progress and results over a period of time can be traced very quickly because the layout will accommodate this.

There is a section on Patents and we know the outstanding important Patents still to come. "The Adder" is the best Patent searcher, I know and his brilliant information is transferred to this library.

That is very important as NRT has a number of Applications at any one time.

There is also a section on supporting literature. This describes a number of Cancers and other diseases connected with the ongoing and pending trials.

NRT is one of the most complex companies on the ASX and this library is very important. THe layout is very logical .

Example: I was asked how to convert NVGN into NRT. The answer is in the library:

14.3 To convert NVGN ( Nasdaq) into NRT ($A):
http://www.ozestock.com.au/MessageView.asp?PostID=203434&Symbol=NRT

So it is a clinical document and is worthwhile having. Other sites have started to follow the same method: PSD and OXR. These are nowhere near as complex but have found that without such a document , the information will be all over the place or simply can't be found.

(CMQ has a simple structure, therefore doesn't require it).
The library has been in operation for some 7 months and Ozestock which has the main NRT site has no problems with it. (There is always the odd objector).

I am prepared to slightly alter the introduction format after some objections on this thread.

+++++++++++++++++++++++++++++++

You wrote:
"I love Gerry’s input as he is passionate about the stock as I am".

Comment: I don't know about the word "passionate". I use a clinical style of writing and do calculations. My presentation is therefore different than that of others.

My previous post will give you a clue. I am not known as the most exuberant contributor on the Ozestock site; nevertheless the stock has some good prospects IMHO.

There is always risk of course and an investor needs to do his/own research. Readers, please avoid putting too much hard earned cash into one company.

Gerry

"Life is either a daring adventure or nothing."
Helen Keller